Abstract
Immune-mediated neuropathies include some specific types such as acute and chronic inflammatory demyelinating polyneuropathy (AIDP and CIDP). Previous studies have demonstrated abnormal cellular or humoral immune responses in these conditions. Although aberrant regulation of several cytokines have been reported in AIDP and CIDP, the significance of interleukin 19 (IL-19) in these conditions have not been elucidated yet. In the current study, we assessed serum levels of IL-19 in 12 CIDP patients (female/male ratio, 4/8), 9 AIDP patients (female/male ratio, 3/6), and 27 normal subjects (female/male ratio. 8/19) using commercial ELISA kits. Notably, we detected higher levels of this cytokine in CIDP patients (136.4 ± 8.57 ng/l) compared with both AIDP patients (93.89 ± 2.26 ng/l) and controls (83.78 ± 1.72 ng/l). However, the differences between AIDP patients and controls were not significant. The current study demonstrates the role of IL-19 in the pathogenesis of CIDP and potentiates this cytokine as a biomarker for this condition.
Similar content being viewed by others
References
Abd Nikfarjam B, Ebtekar M, Sabouni F, Pourpak Z, Kheirandish M (2013) Detection of IL-20R1 and IL-20R2 mRNA in C57BL/6 mice astroglial cells and brain cortex following LPS stimulation. Iran J Immunol 10:62–69
Ali ZPM, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020) Assessment of IL-38 levels in patients with acquired immune-mediated polyneuropathies. J Mol Neurosci
Blumberg H, Conklin D, Xu W, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9–19
Chandra SR, Karru VR, Mukheem Mudabbir MA, Ramakrishnan S, Mahadevan A (2018) Immune-mediated neuropathies our experience over 3 years. Journal of neurosciences in rural practice 9:30–35
Chang C, Magracheva E, Kozlov S, Fong S, Tobin G, Kotenko S, Wlodawer A, Zdanov A (2003) Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278:3308–3313
Chi LJ, Xu WH, Zhang ZW, Huang HT, Zhang LM, Zhou J (2010) Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 15:345–356
Hsu YH, Hsieh PP, Chang MS (2012) Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatology (Oxford) 51:434–442
Köller H, Kieseier BC, Jander S, Hartung H-P (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343–1356
Lehmann HC, Meyer Zu Horste G, Kieseier BC, Hartung H-P (2009) Pathogenesis and treatment of immune-mediated neuropathies. Ther Adv Neurol Disord 2:261–281
Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, Yu CK, Shieh CC, Cheng KC, Lee MF, Chiang SR, Shieh JM, Chang MS (2004) IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173:6712–6718
(1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41:617–618
Nyati KK, Prasad KN (2014) Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome. Mediat Inflamm 2014:758639–758639
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71–109
Van Der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG (2001) Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 45:133–139
Acknowledgments
The current study was supported by a grant number 9712218216 from Hamadan University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare they have no conflict of interest.
The study protocol was approved by the ethical committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1397.948). All study participants signed the informed consent forms.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sangsefidi, S., Ghafouri-Fard, S., Komaki, A. et al. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. J Mol Neurosci 70, 1997–2000 (2020). https://doi.org/10.1007/s12031-020-01602-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01602-y